Silverarc Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$599K | – | 76 |
|
|
2023
Q4 | $599K | Buy |
+10,000
| New | +$599K | 0.18% | 59 |
|
|
2022
Q3 | – | Sell |
-129,795
| Closed | -$5.87M | – | 71 |
|
|
2022
Q2 | $5.87M | Buy |
129,795
+24,427
| +23% | +$1.1M | 1.81% | 13 |
|
|
2022
Q1 | $5.35K | Buy |
+105,368
| New | +$5.35K | 2.22% | 10 |
|
|
2021
Q3 | – | Sell |
-7,009
| Closed | -$443 | – | 82 |
|
|
2021
Q2 | $443 | Buy |
+7,009
| New | +$443 | 0.2% | 79 |
|